e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cardlytics, Inc. - Common Stock
(NQ:
CDLX
)
1.143
-0.007 (-0.65%)
Streaming Delayed Price
Updated: 3:09 PM EST, Dec 31, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cardlytics, Inc. - Common Stock
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Here's Why Cardlytics Stock Sank to an All-Time Low on Wednesday
↗
November 02, 2022
The business trends are worse than management expected.
Via
The Motley Fool
Cardlytics Sees Price Target Cut By 26% To Reflect Macro Headwinds
↗
November 02, 2022
Via
Benzinga
Cardlytics Announces Third Quarter 2022 Financial Results
November 01, 2022
From
Cardlytics, Inc.
Via
GlobeNewswire
Cardlytics Announces Timing of Its Third Quarter 2022 Financial Results Conference Call and Webcast
October 19, 2022
From
Cardlytics, Inc.
Via
GlobeNewswire
What 7 Analyst Ratings Have To Say About Cardlytics
↗
September 08, 2022
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Where Cardlytics Stands With Analysts
↗
August 03, 2022
Analysts have provided the following ratings for Cardlytics (NASDAQ:CDLX) within the last quarter:
Via
Benzinga
Recap: Cardlytics Q2 Earnings
↗
August 02, 2022
Cardlytics (NASDAQ:CDLX) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Where Cardlytics Stands With Analysts
↗
July 14, 2022
Cardlytics (NASDAQ:CDLX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday
↗
October 18, 2022
Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.
Via
Benzinga
10 Communication Services Stocks Moving In Monday's Intraday Session
↗
October 17, 2022
Gainers
Via
Benzinga
Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session
↗
October 17, 2022
Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.
Via
Benzinga
11 Communication Services Stocks Moving In Friday's Intraday Session
↗
October 14, 2022
Gainers
Via
Benzinga
Why Tuesday Morning Shares Tumbled 31%; Here Are 66 Biggest Movers From Yesterday
↗
September 13, 2022
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
Via
Benzinga
11 Communication Services Stocks Moving In Monday's Intraday Session
↗
September 12, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
↗
September 08, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
July 25, 2022
On Monday, 100 companies reached new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 22, 2022
During Friday's session, 61 companies made new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
July 21, 2022
During Thursday's trading, 50 companies set new 52-week lows.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2022
↗
July 14, 2022
Upgrades
Via
Benzinga
Why These Casino Stocks Are Moving Lower, Here's 45 Stocks Moving In Monday's Mid-Day Session
↗
July 11, 2022
Gainers Pliant Therapeutics, Inc. (NASDAQ: PLRX) jumped 112.6% to $18.88 after the company said its treatment for Idiopathic Pulmonary Fibrosis was well tolerated in a Phase 2a study.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
↗
July 13, 2022
Upgrades
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 12, 2022
↗
July 12, 2022
Upgrades
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
July 08, 2022
Friday's session saw 47 companies set new 52-week lows.
Via
Benzinga
Alibaba, Zoom Video And 76 Biggest Movers From Yesterday
↗
July 12, 2022
Gainers Kaspien Holdings Inc. (NASDAQ: KSPN) shares climbed 161.9% to close at $6.81 on Monday on heavy volume amid mention of the stock on social media.
Via
Benzinga
A Look At Needham's Top FinTech Picks
↗
June 16, 2022
After another earnings season and coming off the 17th Annual NTMC, Needham analyst Mayank Tandon received updates from its entire coverage universe in recent weeks.
Via
Benzinga
Tesla, Twitter And 76 Biggest Movers From Friday
↗
July 11, 2022
Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...
Via
Benzinga
Cardlytics: Q1 Earnings Insights
↗
May 02, 2022
Cardlytics (NASDAQ:CDLX) reported its Q1 earnings results on Monday, May 2, 2022 at 05:00 PM. Here's what investors need to know about the announcement. Earnings Cardlytics beat estimated earnings by...
Via
Benzinga
Earnings Scheduled For May 2, 2022
↗
May 02, 2022
Companies Reporting Before The Bell • New Gold (AMEX:NGD) is estimated to report quarterly earnings at $0.03 per share on revenue of $212.42 million.
Via
Benzinga
Earnings Outlook For Cardlytics
↗
April 29, 2022
Cardlytics (NASDAQ:CDLX) is set to give its latest quarterly earnings report on Monday, 2022-05-02. Here's what investors need to know before the announcement. Analysts estimate that Cardlytics will...
Via
Benzinga
12 Communication Services Stocks Moving In Thursday's Intraday Session
↗
April 21, 2022
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.